[go: up one dir, main page]

FI20096331A0 - Using an Antibody - Google Patents

Using an Antibody

Info

Publication number
FI20096331A0
FI20096331A0 FI20096331A FI20096331A FI20096331A0 FI 20096331 A0 FI20096331 A0 FI 20096331A0 FI 20096331 A FI20096331 A FI 20096331A FI 20096331 A FI20096331 A FI 20096331A FI 20096331 A0 FI20096331 A0 FI 20096331A0
Authority
FI
Finland
Prior art keywords
antibody
Prior art date
Application number
FI20096331A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Annika Kotovuori
Suvi Natunen
Valmu Leena
Original Assignee
Suomen Punainen Risti Veripalv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suomen Punainen Risti Veripalv filed Critical Suomen Punainen Risti Veripalv
Priority to FI20096331A priority Critical patent/FI20096331A0/en
Publication of FI20096331A0 publication Critical patent/FI20096331A0/en
Priority to PCT/FI2010/051032 priority patent/WO2011073517A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI20096331A 2009-12-15 2009-12-15 Using an Antibody FI20096331A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20096331A FI20096331A0 (en) 2009-12-15 2009-12-15 Using an Antibody
PCT/FI2010/051032 WO2011073517A1 (en) 2009-12-15 2010-12-15 Method of distinguishing undifferentiated mesenchymal stem cells and differentiated mesenchymal stem cells from each other by using an antibody against the blood group i antigen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20096331A FI20096331A0 (en) 2009-12-15 2009-12-15 Using an Antibody

Publications (1)

Publication Number Publication Date
FI20096331A0 true FI20096331A0 (en) 2009-12-15

Family

ID=41462792

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20096331A FI20096331A0 (en) 2009-12-15 2009-12-15 Using an Antibody

Country Status (2)

Country Link
FI (1) FI20096331A0 (en)
WO (1) WO2011073517A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059523A (en) * 1988-05-02 1991-10-22 Sloan-Kettering Institute For Cancer Research Cell-surface glycoproteins of human sarcomas
US5837539A (en) * 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
AU6144498A (en) * 1997-02-06 1998-08-26 Osiris Therapeutics, Inc. P21cip1 or p27kip1 effects on the regulation of differentiation of human mesenchymal stem cells
US20050158289A1 (en) * 1999-07-07 2005-07-21 Simmons Paul J. Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals
AU2008206887B9 (en) * 2007-01-18 2011-07-07 Glykos Finland Oy Novel specific cell binders

Also Published As

Publication number Publication date
WO2011073517A1 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
PT2406284T (en) ANTI-BCMA ANTIBODIES
BRPI0907237A2 (en) Anti-cldn6 antibody
HRP20171011T1 (en) ANTI-eMET ANTIBODY
BRPI1011005A2 (en) anti-epcam antibodies
EP2473531A4 (en) ANTI-GITR ANTIBODY
BR112012030311A2 (en) antibody
PT2530091T (en) ANTI-DLL3 ANTIBODY
BRPI0906877A2 (en) Improved anti-trkb antibodies
BRPI1006519A2 (en) antibody formulation
IL212175B (en) Antibodies *1muc
EP2406399A4 (en) MIRAC PROTEINS
DK2462134T3 (en) N 1-sulfonyl-5-fluorpyrimidinonderivater
DK2414015T3 (en) LARYNGOSKOPSYSTEM
EP2337798A4 (en) BSA-SPECIFIC ANTIBODIES
EP2377932A4 (en) ANTIBODIES AGAINST SIGLEC-15
BRPI1014262A2 (en) cadherin-17 specific antibodies
SMT201700083B (en) MONOCLONAL ANTIBODIES
CO6791565A2 (en) Anti-notch1 antibodies
DK2930184T3 (en) DKK-1 ANTIBODIES
BRPI1014968A2 (en) underreader
EP2629796A4 (en) ANTIBODY
BRPI0909633A2 (en) anti-tyrp1 antibodies
DE112010002728A5 (en) Turboinhalator
EP2426149A4 (en) ANTI-CADHERINE ANTIBODIES
BRPI0912769A2 (en) anti-pirb antibodies

Legal Events

Date Code Title Description
FD Application lapsed